Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Easy-to-use Bydureon pen cuts down on the hassle of once-weekly injections by offering convenient mixing, a hidden needle, and more​
How it works and why it could help with exercise challenges. Plus, how diaTribe readers can try it for free
Ease, comfort, and actionable patterns, but some challenges with insurance coverage
Device Updates from Abbott, Dexcom, Insulet, Medtronic, and Tandem
Health Canada has approved the once-daily insulin for adults with type 1 and type 2 diabetes
Studies highlight reduced hypoglycemia risk for people with type 2 diabetes who switch to “next-gen” basal insulins Toujeo or Tresiba
Dexcom CGM for Medicare shipments start with hopefully more to come, Ascencia Contour Next One meter added, and why remote monitoring is not enabled
Information about diabetes supplies for those hit by the storms and for those who can help them
Lilly announces new program, in partnership with Express Scripts, to provide insulin directly to people with diabetes and high out of pocket drug expenses
New apps and software updates from mySugr, Insulia, One Drop, as well as food and weight loss apps
Research presented at ADA’s 2017 conference shows exciting advances in a host of diabetes drugs – including heart benefits, improved glucose control, lower cholesterol,...
How do I stay in range while sleeping?
FDA approves Lucentis for all types of diabetic retinopathy and IBM announces a new technology that helps doctors better diagnose retinopathy
A new basal insulin is on the horizon in the US with Merck’s LUSDUNA Nexvue, but launch timing obscured by ongoing lawsuit
Jim Hirsch, diaTribe contributor and bestselling author, weighs in on a damaging diabetes myth
Best-selling author on why he believes “calories in-out” is not an explanation for obesity, why we need better science, and nutrition recommendations for people with...
ADA and AADE publish guidelines for healthcare professionals on word choices that empower people with diabetes
The FDA decision on Novo Nordisk’s basal insulin is based on positive safety and efficacy data of Tresiba versus other basal insulins
By Maeve Serino and Adam Brown Learn about what’s new and what’s coming soon in Smart Pens, automated insulin delivery, pumps, and more Diabetes technology moves fast,...
A major call for creativity, urgency, and new approaches to behavior change from expert panelists at SXSW 2017

Pages